

How Fraud, Greed and Negligence Have Stymied Alzheimer’s Research and Progress Toward a Cure
Feb 3, 2025
Charles Piller, an investigative journalist for Science magazine and author of 'Doctored,' delves into the troubling landscape of Alzheimer’s research. He reveals alarming instances of fraud that have skewed studies and limited progress. Piller discusses the flawed amyloid hypothesis, potential misconduct in drug approvals, and calls for greater transparency in scientific practices. He highlights the emotional toll of Alzheimer's on patients and families, emphasizing the urgent need for accountability to unlock new treatment avenues.
Chapters
Books
Transcript
Episode notes
1 2 3 4 5 6 7 8
Intro
00:00 • 4min
The Impact of Alzheimer's Disease: Memory and Identity Erosion
03:58 • 10min
Rethinking the Amyloid Hypothesis
13:29 • 4min
Fraud and Integrity in Alzheimer's Research
17:55 • 16min
Uncovering Image Manipulation in Alzheimer's Research
34:20 • 3min
Controversies in Alzheimer's Drug Approval
37:28 • 11min
The Replication Crisis in Alzheimer's Research
48:34 • 5min
Examining Accountability in Scientific Research
53:09 • 3min